Posts Tagged ‘ticagrelor’
New Guidelines May Help High-Risk People Live Longer, Healthier Lives
Posted by: admin on: February 28, 2012
Preventing a second episode of Cerebrovascular event and staying healthy and longer in high risk patients is the key to these guidelines given on Nov 3,2011 in GlobeNewswire via COMTEX. Team@CMHF
NSTEMI Guidelines: Are the US and Europe in Harmony?
Posted by: admin on: November 21, 2011
At the ESC meeting in Paris, the new European guidelines on non-ST-segment elevation myocardial infarction were released. -Team@CMHF The updated ACCF/AHA guidelines came out in March 2011. While there is concordance for early invasive management, there are subtle differences relating to adjunctive pharmacologics. For one, ticagrelor was not included in the US update since it […]
New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients with Non-ST Elevation Acute Coronary Syndromes
Posted by: admin on: November 16, 2011
Tricagrelor a platelet aggregation inhibitor used in ST elevation coronary syndrome is being compared to clopidogrel in its use in ACS without ST elevation. Here is the study proving it to be even better than clopidogrel. Team@CMHF
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
